Invesco Dynamic Biotechnology Etf Profile
| PBE Etf | USD 81.55 0.74 0.92% |
PerformanceMild
| Odds Of DistressFair
|
Invesco Dynamic is trading at 81.55 as of the 13th of February 2026, a 0.92 percent increase since the beginning of the trading day. The etf's lowest day price was 80.81. Invesco Dynamic has 47 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. The performance scores are derived for the period starting the 15th of November 2025 and ending today, the 13th of February 2026. Click here to learn more.
The fund generally will invest at least 90 percent of its total assets in securities that comprise the underlying index. Dynamic Biotechnology is traded on NYSEARCA Exchange in the United States. More on Invesco Dynamic Biotechnology
Moving together with Invesco Etf
Invesco Etf Highlights
| Chairman | H Bond |
| Thematic Ideas | (View all Themes) |
| Old Name | Powershares Dynamic Biotech & Genome Portfolio |
| Business Concentration | Sector ETFs, Health Care ETFs, Health, Invesco (View all Sectors) |
| Issuer | Invesco |
| Inception Date | 2005-06-23 |
| Benchmark | Dynamic Biotech & Genome Intellidex Index |
| Entity Type | Regulated Investment Company |
| Asset Under Management | 265.62 Million |
| Average Trading Volume | 8,325.4 |
| Asset Type | Equity |
| Category | Sector |
| Focus | Health Care |
| Market Concentration | Developed Markets |
| Region | North America |
| Administrator | The Bank of New York Mellon Corporation |
| Advisor | Invesco Capital Management, LLC |
| Custodian | The Bank of New York Mellon Corporation |
| Distributor | Invesco Distributors, Inc. |
| Portfolio Manager | Peter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser |
| Transfer Agent | The Bank of New York Mellon Corporation |
| Fiscal Year End | 30-Apr |
| Exchange | NYSE Arca, Inc. |
| Number of Constituents | 30.0 |
| Market Maker | Citadel |
| Total Expense | 0.58 |
| Management Fee | 0.5 |
| Country Name | USA |
| Returns Y T D | (0.32) |
| Name | Invesco Dynamic Biotechnology Genome ETF |
| Currency Code | USD |
| Open Figi | BBG000DTFST2 |
| In Threey Volatility | 17.08 |
| 1y Volatility | 15.93 |
| 200 Day M A | 71.7008 |
| 50 Day M A | 82.3156 |
| Code | PBE |
| Updated At | 12th of February 2026 |
| Currency Name | US Dollar |
Invesco Dynamic Biotechnology [PBE] is traded in USA and was established 2005-06-23. The fund is classified under Health category within Invesco family. The entity is thematically classified as Sector ETFs. Invesco Dynamic Biot at this time have 228.48 M in assets. , while the total return for the last 3 years was 8.1%.
Check Invesco Dynamic Probability Of Bankruptcy
Geographic Allocation (%)
Invesco Dynamic Biot Risk Profiles
The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Invesco Dynamic. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.
| Mean Deviation | 0.8904 | |||
| Semi Deviation | 0.8546 | |||
| Standard Deviation | 1.16 | |||
| Variance | 1.34 |
Invesco Dynamic Biot Technical Analysis
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Invesco Dynamic Biot Tanh Of Price Series is a hyperbolic price transformation function.
Invesco Dynamic Against Markets
Invesco Etf Analysis Notes
Invesco Dynamic is is formed as Regulated Investment Company in the United States. ETF is managed and operated by The Bank of New York Mellon Corporation. The fund has 30 constituents with avarage daily trading value of 8.3 K. The fund charges 0.5 percent management fee with a total expences of 0.58 percent of total asset. The fund maintains 99.9% of assets in stocks. Invesco Dynamic Biot last dividend was 0.029 per share. The fund generally will invest at least 90 percent of its total assets in securities that comprise the underlying index. Dynamic Biotechnology is traded on NYSEARCA Exchange in the United States. To find out more about Invesco Dynamic Biotechnology contact H Bond at 800 983-0903 or learn more at www.invescopowershares.com.Invesco Dynamic Biot Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more etfs at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Invesco Dynamic's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Invesco Dynamic Biotechnology or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| The company reported the last year's revenue of 587.82 K. Reported Net Loss for the year was (265.37 K) with profit before taxes, overhead, and interest of 1.32 M. | |
| Latest headline from news.google.com: Should You Invest in the Invesco Biotechnology Genome ETF - Yahoo Finance | |
| The fund maintains 99.9% of its assets in stocks |
Invesco Dynamic Thematic Classifications
In addition to having Invesco Dynamic etf in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
![]() | Sector ETFsUSA ETFs from Sector clasification | |
![]() | Health Care ETFsUSA ETFs from Health Care clasification |
Invesco Market Capitalization
The company currently falls under 'Small-Cap' category with a total capitalization of 303.13 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Invesco Dynamic's market, we take the total number of its shares issued and multiply it by Invesco Dynamic's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Invesco Dynamic Biotechnology invests in 30 different instruments across multiple market segments that include assets with varying market capitalizations.Invesco Profitablity
The company has Net Profit Margin of (0.01) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average.Management Efficiency
Invesco Dynamic's management efficiency ratios could be used to measure how well Invesco Dynamic manages its routine affairs as well as how well it operates its assets and liabilities.Invesco Dynamic's management has consistently demonstrated strong leadership, driving both financial growth and operational excellence. By analyzing current market trends and future growth opportunities, we assess the stock's true value and potential for investors.
Returns 3 Y 8.13 | Returns 5 Y 0.04 | Returns 1 Y 23.8 | Total Assets 261.9 M | Yield 1 |
Top Invesco Dynamic Biotechnology Etf Constituents
| AKBA | Akebia Ther | Stock | |
| JNJ | Johnson Johnson | Stock | |
| GILD | Gilead Sciences | Stock | |
| FOLD | Amicus Therapeutics | Stock | |
| ABT | Abbott Laboratories | Stock | |
| INCY | Incyte | Stock | |
| ARWR | Arrowhead Pharmaceuticals | Stock | |
| ILMN | Illumina | Stock | |
| PACB | Pacific Biosciences of | Stock | |
| BMY | Bristol Myers Squibb | Stock | |
| RGNX | Regenxbio | Stock | |
| BMRN | Biomarin Pharmaceutical | Stock | |
| FLGT | Fulgent Genetics | Stock | |
| OPK | Opko Health | Stock | |
| CRSP | Crispr Therapeutics AG | Stock | |
| IONS | Ionis Pharmaceuticals | Stock | |
| ALNY | Alnylam Pharmaceuticals | Stock | |
| FGEN | FibroGen | Stock | |
| QGEN | Qiagen NV | Stock | |
| LLY | Eli Lilly and | Stock | |
| NBIX | Neurocrine Biosciences | Stock |
Institutional Etf Holders for Invesco Dynamic
Have you ever been surprised when a price of an equity instrument such as Invesco Dynamic is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Invesco Dynamic Biotechnology backward and forwards among themselves. Invesco Dynamic's institutional investor refers to the entity that pools money to purchase Invesco Dynamic's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Note, although Invesco Dynamic's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses. Invesco Dynamic Outstanding Bonds
Invesco Dynamic issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Invesco Dynamic Biot uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Invesco bonds can be classified according to their maturity, which is the date when Invesco Dynamic Biotechnology has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| INVESCO FIN PLC Corp BondUS46132FAD24 | View | |
| INVESCO FIN PLC Corp BondUS46132FAC41 | View |
Invesco Dynamic Predictive Daily Indicators
Invesco Dynamic intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Invesco Dynamic etf daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Invesco Dynamic Forecast Models
Invesco Dynamic's time-series forecasting models are one of many Invesco Dynamic's etf analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Invesco Dynamic's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Invesco Dynamic Biotechnology. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Invesco Dynamic Biot's market price often diverges from its book value, the accounting figure shown on Invesco's balance sheet. Smart investors calculate Invesco Dynamic's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Invesco Dynamic's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Invesco Dynamic's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Invesco Dynamic should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Invesco Dynamic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
